Adaptive Biotechnologies saw the highest growth of 0.99% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Adaptive Biotechnologies’s patent filings and grants. Buy the databook here.
Adaptive Biotechnologies has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 50% of grants. The Australia(AU), United States(US), European Patent Office(EPO), and Canada(CA) patent Office are among the top ten patent offices where Adaptive Biotechnologies is filings its patents. Among the top granted patent authorities, Adaptive Biotechnologies has 50% of its grants in European Patent Office(EPO) and 50% in Canada(CA).
Blackstone and Immatics could be the strongest competitors for Adaptive Biotechnologies
In terms of grant share, Adaptive Biotechnologies stands in fifth position among its competitors. Blackstone and Immatics secured the top positions according to recent patent publication data.
Patents related to genomics and rare diseases lead Adaptive Biotechnologies's portfolio
Adaptive Biotechnologies has the highest number of patents in genomics followed by, rare diseases and Covid-19. For genomics, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Multiple sclerosis related patents lead Adaptive Biotechnologies portfolio followed by fatigue, and abdominal pain
Adaptive Biotechnologies has highest number of patents in multiple sclerosis followed by fatigue, abdominal pain, diarrhea, and ileitis.
For comprehensive analysis of Adaptive Biotechnologies's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.